Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Case report

Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation

Authors: Maddalena Gigante, Marilena d’Altilia, Eustacchio Montemurno, Sterpeta Diella, Francesca Bruno, Giuseppe S Netti, Elena Ranieri, Giovanni Stallone, Barbara Infante, Giuseppe Grandaliano, Loreto Gesualdo

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Branchio-oto-renal (BOR) syndrome is an autosomal dominant disorder characterized by branchial, ear, and renal anomalies. The most common gene mutated in BOR patients is EYA1, the human homolog of the Drosophila eyes absent gene, while mutations in SIX1 gene, the human homolog of sine oculis, encoding a DNA binding protein interacting with EYA1, have been reported less frequently. Recently, mutations in another SIX family member, SIX5, have been described in BOR patients, however, this association has not been confirmed by other groups.

Case presentation

In this study, we have clinically and genetically characterized a proband that displayed hearing loss, pre-auricular pits, branchial fistulae, hypoplasia of the left kidney, bilateral mild hydronephrosis, progressive proteinuria and focal glomerulosclerosis. Mutational analysis of EYA1 gene revealed a novel splice site mutation, c.1475 + 1G > C, that affects EYA1 splicing and produces an aberrant mRNA transcript, lacking exon 15, which is predicted to encode a truncated protein of 456 aa.

Conclusion

This report provided the functional description of a novel EYA1 splice site mutation and described for the first time a case of BOR syndrome associated with the atypical renal finding of focal glomerulosclerosis, highlighting the importance of molecular testing and detailed clinical evaluation to provide accurate diagnosis and appropriate genetic counselling.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fraser FC, Sproule JR, Halal F: Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet. 1980, 7: 341-349. 10.1002/ajmg.1320070316.CrossRefPubMed Fraser FC, Sproule JR, Halal F: Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet. 1980, 7: 341-349. 10.1002/ajmg.1320070316.CrossRefPubMed
2.
go back to reference Chen A, Francis M, Ni L, Cremers CW, Kimberling WJ, Sato Y, Phelps PD, Bellman SC, Wagner MJ, Pembrey M, Smith RJH: Phenotypic manifestations of branchio - oto - renal syndrome. Am J Med Genet. 1995, 58: 365-370. 10.1002/ajmg.1320580413.CrossRefPubMed Chen A, Francis M, Ni L, Cremers CW, Kimberling WJ, Sato Y, Phelps PD, Bellman SC, Wagner MJ, Pembrey M, Smith RJH: Phenotypic manifestations of branchio - oto - renal syndrome. Am J Med Genet. 1995, 58: 365-370. 10.1002/ajmg.1320580413.CrossRefPubMed
3.
go back to reference Vincent C, Kalatzis V, Abdelhak S, Chaib H, Compain S, Helias J, Vaneecloo FM, Petit C: BOR and BO syndromes are allelic defects of EYA1. Eur J Hum Genet. 1997, 5: 242-246.PubMed Vincent C, Kalatzis V, Abdelhak S, Chaib H, Compain S, Helias J, Vaneecloo FM, Petit C: BOR and BO syndromes are allelic defects of EYA1. Eur J Hum Genet. 1997, 5: 242-246.PubMed
4.
go back to reference Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, Vincent C, Weil D, Cruaud C, Sahly I, Leibovici M, Bitner-Glindzicz M, Francis M, Lacombe D, Vigneron J, Charachon R, Boven K, Bedbeder P, Van RN, Weissenbach J, Petit C: A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet. 1997, 15: 157-164. 10.1038/ng0297-157.CrossRefPubMed Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, Vincent C, Weil D, Cruaud C, Sahly I, Leibovici M, Bitner-Glindzicz M, Francis M, Lacombe D, Vigneron J, Charachon R, Boven K, Bedbeder P, Van RN, Weissenbach J, Petit C: A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet. 1997, 15: 157-164. 10.1038/ng0297-157.CrossRefPubMed
5.
go back to reference Kumar S, Deffenbacher K, Cremers CW, Van Camp G, Kimberling WJ: Branchio-oto-renal syndrome: identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing. Genet Test. 1997–1998, 1: 243-251. 10.1089/gte.1997.1.243.CrossRef Kumar S, Deffenbacher K, Cremers CW, Van Camp G, Kimberling WJ: Branchio-oto-renal syndrome: identification of novel mutations, molecular characterization, mutation distribution, and prospects for genetic testing. Genet Test. 1997–1998, 1: 243-251. 10.1089/gte.1997.1.243.CrossRef
6.
go back to reference Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, Vincent C, Levi-Acobas F, Cruaud C, Le MM, Mathieu M, Konig R, Vigneron J, Weissenbach J, Petit C, Weil D: Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet. 1997, 6: 2247-2255. 10.1093/hmg/6.13.2247.CrossRefPubMed Abdelhak S, Kalatzis V, Heilig R, Compain S, Samson D, Vincent C, Levi-Acobas F, Cruaud C, Le MM, Mathieu M, Konig R, Vigneron J, Weissenbach J, Petit C, Weil D: Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum Mol Genet. 1997, 6: 2247-2255. 10.1093/hmg/6.13.2247.CrossRefPubMed
7.
go back to reference Chang EH, Menezes M, Meyer NC, Cucci RA, Vervoort VS, Schwartz CE, Smith RJ: Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat. 2004, 23: 582-589. 10.1002/humu.20048.CrossRefPubMed Chang EH, Menezes M, Meyer NC, Cucci RA, Vervoort VS, Schwartz CE, Smith RJ: Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat. 2004, 23: 582-589. 10.1002/humu.20048.CrossRefPubMed
8.
go back to reference Sanggaard KM, Rendtorff ND, Kjaer KW, Eiberg H, Johnsen T, Gimsing S, Dyrmose J, Nielsen KO, Lage K, Tranebjaerg L: Branchio-otorenal syndrome: detection of EYA1 and SIX1 mutations in five out of six Danish families by combining linkage, MLPA and sequencing analyses. Eur J Hum Genet. 2007, 15: 1121-1131. 10.1038/sj.ejhg.5201900.CrossRefPubMed Sanggaard KM, Rendtorff ND, Kjaer KW, Eiberg H, Johnsen T, Gimsing S, Dyrmose J, Nielsen KO, Lage K, Tranebjaerg L: Branchio-otorenal syndrome: detection of EYA1 and SIX1 mutations in five out of six Danish families by combining linkage, MLPA and sequencing analyses. Eur J Hum Genet. 2007, 15: 1121-1131. 10.1038/sj.ejhg.5201900.CrossRefPubMed
9.
go back to reference Orten DJ, Fischer SM, Sorensen JL, Radhakrishna U, Cremers CW, Marres HA, Van Camp G, Welch KO, Smith RJ, Kimberling WJ: Branchio-Oto-Renal Syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR. Hum Mutat. 2008, 29: 537-544. 10.1002/humu.20691.CrossRefPubMed Orten DJ, Fischer SM, Sorensen JL, Radhakrishna U, Cremers CW, Marres HA, Van Camp G, Welch KO, Smith RJ, Kimberling WJ: Branchio-Oto-Renal Syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR. Hum Mutat. 2008, 29: 537-544. 10.1002/humu.20691.CrossRefPubMed
10.
go back to reference Krug P, Morinière V, Marlin S, Koubi V, Gabriel HD, Colin E, Bonneau D, Salomon R, Antignac C, Heidet L: Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harbouring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations. Hum Mutat. 2011, 32: 183-190. 10.1002/humu.21402.CrossRefPubMed Krug P, Morinière V, Marlin S, Koubi V, Gabriel HD, Colin E, Bonneau D, Salomon R, Antignac C, Heidet L: Mutation screening of the EYA1, SIX1, and SIX5 genes in a large cohort of patients harbouring branchio-oto-renal syndrome calls into question the pathogenic role of SIX5 mutations. Hum Mutat. 2011, 32: 183-190. 10.1002/humu.21402.CrossRefPubMed
11.
go back to reference Zou D, Silvius D, Rodrigo-Blomqvist S, Enerbäck S, Xu PX: Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear. Dev Biol. 2006, 298: 430-441. 10.1016/j.ydbio.2006.06.049.CrossRefPubMed Zou D, Silvius D, Rodrigo-Blomqvist S, Enerbäck S, Xu PX: Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear. Dev Biol. 2006, 298: 430-441. 10.1016/j.ydbio.2006.06.049.CrossRefPubMed
12.
go back to reference Brugmann SA, Moody SA: Induction and specification of the vertebrate ectodermal placodes: precursors of the cranial sensory organs. Biol Cell. 2005, 97: 303-319. 10.1042/BC20040515.CrossRefPubMed Brugmann SA, Moody SA: Induction and specification of the vertebrate ectodermal placodes: precursors of the cranial sensory organs. Biol Cell. 2005, 97: 303-319. 10.1042/BC20040515.CrossRefPubMed
13.
go back to reference Dressler GR: The cellular basis of kidney development. Annu Rev Cell Dev Biol. 2006, 22: 509-529. 10.1146/annurev.cellbio.22.010305.104340.CrossRefPubMed Dressler GR: The cellular basis of kidney development. Annu Rev Cell Dev Biol. 2006, 22: 509-529. 10.1146/annurev.cellbio.22.010305.104340.CrossRefPubMed
14.
go back to reference Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, Rosenfeld MG: Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature. 2003, 426: 247-254. 10.1038/nature02083.CrossRefPubMed Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, Rosenfeld MG: Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature. 2003, 426: 247-254. 10.1038/nature02083.CrossRefPubMed
15.
go back to reference Okada M, Fujimaru R, Morimoto N, Satomura K, Kaku Y, Tsuzuki K, Nozu K, Okuyama T, Iijima K: EYA1 and SIX1 gene mutations in Japanese patients with branchio-oto-renal (BOR) syndrome and related conditions. Pediatr Nephrol. 2006, 21: 475-481. 10.1007/s00467-006-0041-6.CrossRefPubMed Okada M, Fujimaru R, Morimoto N, Satomura K, Kaku Y, Tsuzuki K, Nozu K, Okuyama T, Iijima K: EYA1 and SIX1 gene mutations in Japanese patients with branchio-oto-renal (BOR) syndrome and related conditions. Pediatr Nephrol. 2006, 21: 475-481. 10.1007/s00467-006-0041-6.CrossRefPubMed
16.
go back to reference Hoskins BE, Cramer CH, Silvius D, Zou D, Raymond RM, Orten DJ, Kimberling WJ, Smith RJ, Weil D, Petit C, Otto EA, Xu PX, Hildebrandt F: Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet. 2007, 80: 800-804. 10.1086/513322.CrossRefPubMedPubMedCentral Hoskins BE, Cramer CH, Silvius D, Zou D, Raymond RM, Orten DJ, Kimberling WJ, Smith RJ, Weil D, Petit C, Otto EA, Xu PX, Hildebrandt F: Transcription factor SIX5 is mutated in patients with branchio-oto-renal syndrome. Am J Hum Genet. 2007, 80: 800-804. 10.1086/513322.CrossRefPubMedPubMedCentral
17.
go back to reference Melnick M, Bixler D, Silk K, Nance WE: Autosomal dominant branchio-oto-renal dysplasia. Birth defects. Birth Defects Orig Artic Ser. 1975, 11: 121-128.PubMed Melnick M, Bixler D, Silk K, Nance WE: Autosomal dominant branchio-oto-renal dysplasia. Birth defects. Birth Defects Orig Artic Ser. 1975, 11: 121-128.PubMed
18.
go back to reference Stockley TL, Mendoza-Londono R, Propst EJ, Sodhi S, Dupuis L, Papsin BC: A recurrent EYA1 mutation causing alternative RNA splicing in branchio-oto-renal syndrome: implications for molecular diagnostics and disease mechanism. Am J Med Genet A. 2009, 149A: 322-327. 10.1002/ajmg.a.32679.CrossRefPubMed Stockley TL, Mendoza-Londono R, Propst EJ, Sodhi S, Dupuis L, Papsin BC: A recurrent EYA1 mutation causing alternative RNA splicing in branchio-oto-renal syndrome: implications for molecular diagnostics and disease mechanism. Am J Med Genet A. 2009, 149A: 322-327. 10.1002/ajmg.a.32679.CrossRefPubMed
19.
go back to reference Mutsuddi M, Chaffee B, Cassidy J, Silver SJ, Tootle TL, Rebay I: Using Drosophila to decipher how mutations associated with human branchio-oto-renal syndrome and optical defects compromise the protein tyrosine phosphatase and transcriptional functions of eyes absent. Genetics. 2005, 170: 687-695. 10.1534/genetics.104.039156.CrossRefPubMedPubMedCentral Mutsuddi M, Chaffee B, Cassidy J, Silver SJ, Tootle TL, Rebay I: Using Drosophila to decipher how mutations associated with human branchio-oto-renal syndrome and optical defects compromise the protein tyrosine phosphatase and transcriptional functions of eyes absent. Genetics. 2005, 170: 687-695. 10.1534/genetics.104.039156.CrossRefPubMedPubMedCentral
20.
go back to reference Bellini C, Piaggio G, Massocco D, Perfumo F, Bertini , Gusmano R, Serra G: Branchio-oto-renal syndrome: a report on nine family groups. Am J Kidney Dis. 2001, 37: 505-509. 10.1053/ajkd.2001.22074.CrossRefPubMed Bellini C, Piaggio G, Massocco D, Perfumo F, Bertini , Gusmano R, Serra G: Branchio-oto-renal syndrome: a report on nine family groups. Am J Kidney Dis. 2001, 37: 505-509. 10.1053/ajkd.2001.22074.CrossRefPubMed
Metadata
Title
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation
Authors
Maddalena Gigante
Marilena d’Altilia
Eustacchio Montemurno
Sterpeta Diella
Francesca Bruno
Giuseppe S Netti
Elena Ranieri
Giovanni Stallone
Barbara Infante
Giuseppe Grandaliano
Loreto Gesualdo
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-60

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.